Panacea Innovation Ltd - Significant Ownership

Signature - Title
/s/ James Huang - James Huang, Founding Managing Partner
Location
Grand Cayman, Cayman Islands
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Panacea Innovation Ltd.

Email me when Panacea Innovation Ltd files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Panacea Innovation Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CNTB Connect Biopharma Holdings Limited Ordinary Shares 25.1% $14M 14M Panacea Innovation Limited Jul 21, 2025
CNTB Connect Biopharma Holdings Limited Ordinary Shares 21.5% $21.8M 12M Panacea Innovation Limited Nov 24, 2025
ATRA Atara Biotherapeutics, Inc. Common Stock 20% 1.71M +4.54% Panacea Innovation Limited Aug 15, 2025
CASI CASI Pharmaceuticals, Inc. Ordinary Shares 19.9% $8.38M 3.66M James Huang Sep 26, 2025
ATRA Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share 9.5% $4.18M 550K Panacea Venture Healthcare Fund II, L.P. Jan 30, 2025
ADAG Adagene Inc. Ordinary Shares 3.8% $4.47M -$1.56M 2.25M -25.9% Panacea Venture Healthcare Fund II, L.P. Sep 30, 2025
AMLX Amylyx Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.6% $11.8M 2.2M Panacea Venture Healthcare Fund II, L.P. Dec 31, 2024
MRNS Marinus Pharmaceuticals, Inc. Common Stock 0% $0 0 Panacea Venture Healthcare Fund II, L.P. Dec 31, 2024

Schedules 13D/G Reported by Panacea Innovation Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.